Variation Of Normal Protein Could Be Key To Resistance To Common Cancer Drug
Friday, August 29, 2008 - 10:35
in Health & Medicine
Researchers have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.
Read the whole article on Science Daily
More from Science Daily
Related
- Variation of normal protein could be key to resistance to common cancer drugThu, 28 Aug 2008, 11:15:35 EDT
- Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapyThu, 26 Mar 2009, 14:30:30 EDT
- CSHL scientists correlate enzyme expression levels with chemotherapy drug responseFri, 18 Jul 2008, 12:07:44 EDT
- Identifying the potential for tamoxifen resistance in patientsWed, 10 Jun 2009, 16:43:34 EDT
- 3-drug chemotherapy combination increases organ preservation in patients with larynx cancerTue, 24 Mar 2009, 17:15:35 EDT